We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.02B
AUM Growth
+$31.2M
Cap. Flow
-$130M
Cap. Flow %
-6.43%
Top 10 Hldgs %
16.17%
Holding
2,969
New
1,707
Increased
193
Reduced
681
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 12.58%
3 Industrials 10.34%
4 Healthcare 9.4%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$132B
$5.17M 0.26%
95,095
-11,644
-11% -$639K
PEP icon
52
PepsiCo
PEP
$190B
$5.14M 0.25%
45,996
+1,676
+4% +$180K
QCOM icon
53
Qualcomm
QCOM
$176B
$5.12M 0.25%
89,272
-3,867
-4% -$224K
BIIB icon
54
Biogen
BIIB
$30.7B
$5.1M 0.25%
18,662
-999
-5% -$282K
LOW icon
55
Lowe's Companies
LOW
$125B
$5.09M 0.25%
61,987
-4,395
-7% -$336K
OXY icon
56
Occidental Petroleum
OXY
$55.9B
$5.04M 0.25%
79,614
-3,756
-5% -$250K
GD icon
57
General Dynamics
GD
$106B
$4.97M 0.25%
26,555
+2,036
+8% +$376K
AIG icon
58
American International
AIG
$41.3B
$4.96M 0.25%
79,499
-7,029
-8% -$451K
PNC icon
59
PNC Financial Services
PNC
$101B
$4.96M 0.25%
41,243
-3,437
-8% -$421K
NEE icon
60
NextEra Energy
NEE
$177B
$4.9M 0.24%
152,724
-6,976
-4% -$219K
LLY icon
61
Eli Lilly
LLY
$1.06T
$4.85M 0.24%
57,626
-3,824
-6% -$306K
PFE icon
62
Pfizer
PFE
$153B
$4.81M 0.24%
148,146
-8,076
-5% -$255K
ABT icon
63
Abbott
ABT
$187B
$4.75M 0.24%
106,938
+7,771
+8% +$336K
GILD icon
64
Gilead Sciences
GILD
$165B
$4.66M 0.23%
68,606
-3,019
-4% -$212K
TJX icon
65
TJX Companies
TJX
$178B
$4.66M 0.23%
117,810
-9,682
-8% -$373K
IBM icon
66
IBM
IBM
$224B
$4.59M 0.23%
27,606
+807
+3% +$135K
ALGN icon
67
Align Technology
ALGN
$12.3B
$4.46M 0.22%
38,844
-1,531
-4% -$155K
CFR icon
68
Cullen/Frost Bankers
CFR
$10.2B
$4.45M 0.22%
49,982
+25,822
+107% +$2.32M
PM icon
69
Philip Morris
PM
$295B
$4.31M 0.21%
38,160
-1,397
-4% -$144K
IJK icon
70
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$4.27M 0.21%
89,452
-1,700
-2% -$80.2K
HD icon
71
Home Depot
HD
$355B
$4.26M 0.21%
29,023
-913
-3% -$129K
CVS icon
72
CVS Health
CVS
$122B
$4.19M 0.21%
53,395
-1,779
-3% -$142K
EOG icon
73
EOG Resources
EOG
$70.7B
$4.19M 0.21%
42,927
-2,665
-6% -$266K
DFS
74
DELISTED
Discover Financial Services
DFS
$4.15M 0.21%
60,722
-5,709
-9% -$401K
DHR icon
75
Danaher
DHR
$144B
$4.11M 0.2%
54,258
-4,461
-8% -$332K

Similar funds

Ameritas Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ameritas Investment Partners held 2,969 positions worth $2.02B, up 1.6% from $1.99B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameritas Investment Partners withdrew a net $130M in Q1 2017, closing 23 positions and reducing 681 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Bioverativ Inc. Common Stock worth $2.4M.

  • Ameritas Investment Partners's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 44,128 shares worth $2.4M.
  • Ameritas Investment Partners added most to State Street Health Care Select Sector SPDR ETF in Q1 2017, an estimated $2.78M increase.
  • Ameritas Investment Partners's biggest Q1 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $61.8M.
  • Ameritas Investment Partners fully exited Vanguard Total Bond Market in Q1 2017, selling an estimated $34M.
  • Ameritas Investment Partners's ten largest holdings make up 16% of its $2.02B portfolio in Q1 2017.
  • Ameritas Investment Partners opened 1,707 new positions and closed 23 in Q1 2017.
  • Ameritas Investment Partners's portfolio value rose 1.6% quarter-over-quarter to $2.02B.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.